Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • TOBACCO—5th Cir.: No error in preliminary enjoinment of new tobacco warnings rule
    • DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: Frequently Asked Questions—Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
    • DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; Availability
    • EMTALA—E.D.N.Y.: Patient unsuccessful in asserting ADA, EMTALA, and civil rights claims against hospital, NYSDHR
    • EXPERT INSIGHTS—The Remote Monitoring Reckoning: What CMS's CY 2027 Proposed Rule Means For Providers And Vendors
    • MISBRANDING (FOOD, DRUGS & MEDICAL DEVICES)—E.D. Cal.: Acne drug claims survive preemption challenge
    • PRESCRIPTION DRUGS—E.D. Penn.: Class action seeking recovery of payments for hyper inflated drug price dismissed
    • TOBACCO—E.D.N.Y.: Court dismisses defective design claim against R.J. Reynolds
    • VITAL BRIEFING: CMS restricts federal Medicaid funding for youth gender-affirming care, setting up legal challenges
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, VITAL BRIEFING: CMS restricts federal Medicaid funding for youth gender-affirming care, setting up legal challenges, (Aug 21, 2026)

    By Sheila Lynch-Afryl, J.D., M.A.

    Beginning October 13, CMS’ final rule prohibits the use of federal Medicaid funds for “sex-rejecting procedures” for beneficiaries under 18.

    Since taking office in January 2025, the Trump Administration has pursued a series of exe ...

    By Sheila Lynch-Afryl, J.D., M.A.

    Beginning October 13, CMS’ final rule prohibits the use of federal Medicaid funds for “sex-rejecting procedures” for beneficiaries under 18.

    Since taking office in January 2025, the Trump Administration has pursued a series of executive, regulatory, and enforcement actions aimed at limiting access to gender-affirming medical care for minors. Those efforts reached a significant milestone on August 13, when CMS finalized a rule prohibiting federal Medicaid and CHIP funding for gender-affirming care provided to children and adolescents. The rule carries substantial implications for states, beneficiaries, providers, and health systems, while setting the stage for further litigation.

    To read the entire article, click here.

    MainStory: StrategicPerspectives AgencyNews BillingNews CMSNews CoverageNews EligibilityNews MedicaidNews FedTracker HealthCare

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use